anonymous
Guest
anonymous
Guest
MorphoSys CEO eats own words after mixed trial results
MorphoSys, after saying AbbVie 'failed,' defends own mixed blood cancer data, plots approval filings
MorphoSys, after saying AbbVie 'failed,' defends own mixed blood cancer data, plots approval filings